From this study, PYY may potentially be considered a tumor-suppressor for CRC, as was suggested by a recent proteomic study demonstrating its low expression in CRC tissues and proposing it as a potential therapeutic target due to its ability to promote apoptosis and inhibit the proliferation, migration, and invasion of CRC-cell lines [79]. The gene discussed is PYY; the disease is colorectal carcinoma.